ALLO vs HAL · rev $22.0K vs P/E 9.3, $19.05B cap
Allogene Therapeutics Inc (ALLO) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
HAL does not have a complete income-statement cache yet.
ALLO currently screens at market cap $258.1M. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the ALLO and HAL stock pages for the full models.
Not investment advice.